Hours after my last post, I may have had all-time low expectations for Robin Hood. This week’s episode, however, made me eyes perk up a bit. Oh, sure, the latest “twist” of a long-lost brother is somewhat cliche, but what a brother he is. I approve. A lot.
All I ask is that in the future SPN-level fanfics (and there *will* be fics), Guy is just a lookout or something. Ha!
Resistance is an increasing concern, particularly among non-albicans Candida species like C. glabrata and C. krusei.
Diflucan lacks activity against Histoplasma in the CNS, unlike itraconazole.
Diflucan is not effective for primary treatment of fungal brain abscesses.
Diflucan should be avoided in patients with known hypersensitivity to other azoles.
Diflucan can cause taste distortion (dysgeusia) as a side effect.
Hepatic metabolism becomes more significant in patients with end-stage renal disease.
Diflucan is not active against the dimorphic fungus Blastomyces dermatitidis.
Diflucan is often used in pediatric antifungal therapy with weight-based dosing.
Its use in veterinary medicine parallels many human applications.
Represents a critical tool whose utility is now carefully balanced against the rising tide of antifungal resistance.
Protein binding is relatively low (~12), contributing to good tissue distribution.
Diflucan is a substrate of CYP2C9 and CYP3A4, but autoinhibition is minimal.
Diflucan is ineffective against Candida auris, a major multidrug-resistant pathogen.
Diflucan’s success spurred development of broader-spectrum triazoles like voriconazole.
Diflucan can cause a severe cutaneous reaction like Stevens-Johnson syndrome.
Diflucan is a potent inhibitor of human CYP2C9 and CYP3A4, driving many drug interactions.
Its simplicity of use made it a cornerstone of early outpatient HIV management.
Diflucan dosing in continuous renal replacement therapy must account for effluent rate.
Excellent CSF penetration makes it a mainstay for cryptococcal meningitis suppression.
Diflucan can cause headaches and gastrointestinal upset as common side effects.
Its simplicity of use made it a cornerstone of early outpatient HIV management.
Diflucan is a triazole, distinguishing it from the earlier, less selective imidazole class.
Resistance to Diflucan is a growing concern, particularly with Candida glabrata and krusei.
Diflucan can be considered for treatment of Malassezia folliculitis.
Diflucan’s efficacy can be reduced by concomitant use of rifampin.
Diflucan’s mechanism is inhibition of fungal cytochrome P450, disrupting ergosterol synthesis.
Prophylaxis in neutropenic patients is a common use, guided by local resistance patterns.
Has largely replaced ketoconazole for systemic therapy due to a superior safety profile.
The single-dose Diflucan regimen for vulvovaginal candidiasis revolutionized patient self-care.
Diflucan is often the first systemic antifungal agents that clinicians learn to use.
Alopecia is a reversible but distressing side effect reported with prolonged use.
Diflucan can lead to clinically significant interactions with immunosuppressants like tacrolimus.
Diflucan has reliable activity against Coccidioides immitis for certain non-meningeal cases.
Its chemical stability contributes to a long shelf life and easy formulation.
Not recommended for empirical treatment of serious infections in critically ill patients.
Diflucan is not a substrate of the P-glycoprotein efflux pump, aiding its distribution.
Represents a critical tool whose utility is now carefully balanced against the rising tide of antifungal resistance.
Can be used for chronic suppressive therapy in recurrent mucosal candidiasis.
Breakthrough infections during prophylaxis are a significant clinical red flag.
Hydrochlorothiazide can increase fluconazole levels by reducing renal clearance.
Its water solubility is a distinct advantage over older imidazole antifungals.
Multiple drug interactions stem from its inhibition of human CYP2C9 and CYP3A4.
Renal dose adjustment is mandatory for Diflucan due to its primary renal excretion.
Diflucan can significantly increase serum concentrations of statins, raising myopathy risk.
Hepatic metabolism becomes more significant in patients with end-stage renal disease.
Plays a role in selective digestive decontamination protocols in some ICU settings.
Diflucan has a post-antimicrobial effect against some Candida species.
The long half-life (~30 hours) enables convenient once-daily dosing regimens.
Diflucan is often used for esophageal candidiasis in immunocompromised hosts.
Diflucan is a key agent whose utility is being challenged by shifting resistance patterns.